Claims for Patent: 12,280,146
✉ Email this page to a colleague
Summary for Patent: 12,280,146
| Title: | Nanoemulsion without propylene glycol |
| Abstract: | The present invention relates to oil in water nanoemulsions which are essentially free of propylene glycol. The nanovesicle formulations are particularly stable in regard to shelf life at different storage temperatures. |
| Inventor(s): | Montserrat FOGUET, Lars MÖLLMANN |
| Assignee: | Biofrontera Bioscience GmbH |
| Application Number: | US18/533,497 |
| Patent Claims: |
1. A formulation comprising: (a) a nanoemulsion comprising: (i) at least one aqueous component; (ii) a carrier component comprising: (1) at least one lipophilic component, (2) at least one surfactant, and (3) at least one alcohol; and (b) 5-aminolevulinic acid and/or a derivative, a precursor, a metabolite, and/or a pharmaceutically acceptable salt thereof, wherein the formulation comprises essentially no propylene glycol and essentially no sorbitol. 2. The formulation of claim 1, wherein the formulation further comprises less than 1% w/w of a non-cyclic polyol having 2 to 5 carbon atoms. 3. The formulation of claim 1, wherein the formulation further comprises less than 1% w/w of a non-cyclic polyol having 2 to 12 carbon atoms. 4. The formulation of claim 1, wherein the at least one alcohol comprises: 3, 4, or 5 carbon atoms; or 1-propanol, 2-propanol, or a mixture thereof. 5. The formulation of claim 1, comprising the at least one aqueous component in an amount from 50% to 99% (w/w), from 70% to 95% (w/w), from 75% to 95% (w/w), or from 80% to 90% (w/w). 6. The formulation of claim 4, comprising the at least one lipophilic component in an amount from 0.1% to 30% (w/w), from 0.25% to 15% (w/w), from 0.25% to 10% (w/w), from 2% to 10% (w/w), or 3% to 8% (w/w) based on total weight of the nanoemulsion. 7. The formulation of claim 1, wherein the formulation comprises no propylene glycol. 8. The formulation of claim 1, wherein the formulation further comprises less than or equal to 0.99%, 0.95%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, or 0.1% w/w of a non-cyclic polyol having 2 to 5 carbon atoms. 9. The formulation of claim 1, wherein the formulation further comprises essentially no non-cyclic polyol having 2 to 5 carbon atoms. 10. The formulation of claim 1, wherein the formulation further comprises no non-cyclic polyol having 2 to 5 carbon atoms. 11. The formulation of claim 1, wherein the formulation further comprises less than or equal to 0.99%, 0.95%, 0.9%, 0.8%, 0.7%, 0.6%, 0.5%, 0.4%, 0.3%, 0.2%, or 0.1% w/w of a non-cyclic polyol having 2 to 12 carbon atoms. 12. The formulation of claim 1, wherein the formulation further comprises essentially no non-cyclic polyol having 2 to 12 carbon atoms. 13. The formulation of claim 1, wherein the formulation further comprises no non-cyclic polyol having 2 to 12 carbon atoms. 14. The formulation of claim 1, wherein the at least one lipophilic component comprises: triglycerides and/or mixtures thereof; or a caprylic triglyceride, a capric triglyceride, or a mixture thereof. 15. The formulation of claim 1, wherein the at least one surfactant comprises: a phospholipid, a phosphatidylcholine, a lysophospholipid, a ceramide, and/or a mixture thereof; and/or a polyoxyethylene-type surfactant. 16. The formulation of claim 4, wherein the at least one alcohol is in an amount from 0.1% to 10% (w/w), from 0.5% to 5% (w/w), from 1% to 5% (w/w), or from 1% to 3% based on total weight of the nanoemulsion. 17. The formulation of claim 1, wherein the formulation further comprises essentially no monosaccharides and disaccharides. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
